AstraZeneca Sued Dr. Reddys on Brilinta Patents
AstraZeneca Sued Dr. Reddys on Brilinta Patents AstraZeneca has filed a lawsuit in the Delhi High Court against Indian drug maker Dr Reddy’s Laboratories to block it from launching generic versions…
Sticking to core values of giving the best quality, reduced timelines, customer centric approach, 24×7 availability and giving the best value for customer’s money made IMMUNIS IP a unique Patent service provider for the customers.
Copyright © 2023 IMMUNIS IP. All Rights Reserved. Build with by Digital GYB